JingXia Cui
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
- Biomaterials 18
- Nanoparticle-Based Drug Delivery 17
-
- RNA Interference and Gene Delivery 8
- Natural product bioactivities and synthesis 4
- Phytochemical Studies and Bioactivities 3
- Co-authors
- Yanhui Li (13 shared papers)Caixia Wang (11 shared papers)Chunlei Li (11 shared papers)Chunlei Li (6 shared papers)Lan Zhang (8 shared papers)Li Zhang (8 shared papers)Yongli Wang (5 shared papers)Na Wei (8 shared papers)
- Journals
- International Journal of Pharmaceutics (7 papers)Journal of Pharmacy and Pharmacology (5 papers)Journal of Pharmaceutical Sciences (2 papers)Cell Proliferation (2 papers)Infection and Drug Resistance (1 paper)
- Partner nations
- ChinaSouth Korea
In The Last Decade
JingXia Cui
27 papers receiving 727 citations
Peers
Comparison fields: 5 of 92
- Biomaterials 376
- Pharmaceutical Science 109
- Molecular Medicine 36
- Molecular Biology 400
- Oncology 101
Countries citing papers authored by JingXia Cui
This map shows the geographic impact of JingXia Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JingXia Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JingXia Cui more than expected).
Fields of papers citing papers by JingXia Cui
This network shows the impact of papers produced by JingXia Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JingXia Cui. The network helps show where JingXia Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside JingXia Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 96 | |
| 2 | 2014 | 70 | |
| 3 | 2006 | 50 | |
| 4 | 2012 | 45 | |
| 5 | 2008 | 42 | |
| 6 | 2013 | 39 | |
| 7 | 2008 | 38 | |
| 8 | 2008 | 35 | |
| 9 | 2008 | 31 | |
| 10 | 2018 | 31 | |
| 11 | 2017 | 30 | |
| 12 | 2011 | 27 | |
| 13 | 2020 | 27 | |
| 14 | 2008 | 22 | |
| 15 | 2013 | 19 | |
| 16 | 2011 | 19 | |
| 17 | 2018 | 18 | |
| 18 | 1999 | 18 | |
| 19 | 2017 | 18 | |
| 20 | 2008 | 16 |
About JingXia Cui
JingXia Cui is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Pulmonary and Respiratory Medicine and Pharmaceutical Science, having authored 27 papers that have together received 736 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (17 papers), RNA Interference and Gene Delivery (8 papers), Nanoplatforms for cancer theranostics (4 papers), Natural product bioactivities and synthesis (4 papers), Inhalation and Respiratory Drug Delivery (3 papers), Phytochemical Studies and Bioactivities (3 papers), Advanced Drug Delivery Systems (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Biomaterials (376 citations), Pharmaceutical Science (109 citations), Molecular Medicine (36 citations), Molecular Biology (400 citations) and Oncology (101 citations). JingXia Cui has collaborated with scholars based in China and South Korea. Frequent co-authors include Yanhui Li, Caixia Wang, Chunlei Li, Chunlei Li, Lan Zhang, Li Zhang, Yongli Wang, Na Wei, Wenmin Guo and Shuli Man. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Pharmacy and Pharmacology, Journal of Pharmaceutical Sciences, Cell Proliferation and Infection and Drug Resistance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.